Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FAZGL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $29.7K to DMS Pharmaceutical Group Inc. for the supply of Entyvio 300 mg vials. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, which serves as both the place of performance and the contractor's headquarters. The delivery order is firm fixed-price in nature with an ultimate completion date of May 12, 2025, and no set-aside designation was utilized in the award. This contract was issued without a competitive set-aside, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $500 million and extending through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, consistently delivering specialized medical products ranging from oncology treatments to vaccines and other specialty pharmaceuticals to military health systems.
Quick answers
Who was awarded contract SPE2DB25FAZGL?
SPE2DB25FAZGL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 21, 2025.
How much is contract SPE2DB25FAZGL worth?
The government has obligated $29,670 on SPE2DB25FAZGL.
Is contract SPE2DB25FAZGL an order under another contract?
Yes. SPE2DB25FAZGL is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZGL competed?
The extent of competition for SPE2DB25FAZGL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award